LONDON, May 16 /PRNewswire/ Eisai Europe Ltd announced today that results from 9 clinical data abstracts about compounds in the company s oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicag
Analysis Evaluates Efficacy of Eribulin in Metastatic HER2-low Breast Cancer Across Three Clinical StudiesTOKYO, Sept 12, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today results from a post hoc